Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans

Journal of Physiology

Volumn 548, Issue 2, 2003, Pages 631-638

  Steensberg, Adam ^a,b   Fischer, Christian P ^a,b   Sacchetti, Massimo ^a   Keller, Charlotte ^a,b   Osada, Takuya ^a   Schjerling, Peter ^a   van Hall, Gerrit ^a   Febbraio, Mark A ^a,c   Pedersen, Bente Klarlund ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DEUTERIUM; GLUCOSE; INTERLEUKIN 6; ISOTOPE; RECOMBINANT INTERLEUKIN 6; SODIUM CHLORIDE;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CONTROLLED STUDY; FEMORAL ARTERY; FOREARM; GLUCONEOGENESIS; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; INFUSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; SHIVERING; STATISTICAL ANALYSIS; SYMPTOM; VEIN; GLUCOSE ASSAY; HUMAN TISSUE; LEG; MUSCLE GLUCOSE UPTAKE;

ADULT; BLOOD PRESSURE; ENERGY METABOLISM; EPINEPHRINE; EXERCISE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; NOREPINEPHRINE; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW; RNA, MESSENGER;

EID: 0038745434     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.032938     Document Type: Article

References (28)

1. Asp S, Daugaard JR, Kristiansen S, Kiens B & Richter EA (1996). Eccentric exercise decreases maximal insulin action in humans: muscle and systemic effects. J Physiol 494, 891-898.
2. Blomstrand E & Saltin B (1999). Effect of muscle glycogen on glucose, lactate and amino acid metabolism during exercise and recovery in human subjects. J Physiol 514, 293-302.
3. Febbraio MA, Steensberg A, Fischer CP, Keller C, Hiscock N & Pedersen BK (2002). IL-6 activates HSP72 gene expression in human skeletal muscle. Biochem Biophys Res Comm 296, 1264-1266.
4. Febbraio MA & Pedersen BK (2002). Muscle derived inerleukin-6: mechanisms for activation and possible biological roles. FASEB J 16, 1335-1347.
5. Gleeson M (2000). Interleukins and exercise. J Physiol 529, 1.
6. Hardin J, Kroeker K, Chung B & Gall DG (2000). Effect of proinflammatory interleukins on jejunal nutrient transport. Gut 47, 184-191.
7. Helge JW, Stallnecht B, Pedersen BK, Galbo H, Kiens B & Richter EA (2003). The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. J Physiol 546, 299-309.
8. Hotamisligil GS (1999). The role of TNFalpha and TNF receptors in obesity and insulin resistance. Intern Med 245, 621-625.
9. Jansson E, Hjemdahl P & Kaijser L (1986). Epinephrine induced changes in muscle carbohydrate metabolism during exercise in male subjects. J Appl Physiol 60, 1466-1470.
10. Keller C, Steensberg A, Pilegaard H, Pedersen BK & Neufer D (2001). Transcriptional activation of the IL-6 gene in human contracting skeletal muscle-influence of muscle glycogen content. FASEB J 15, 2748-2750.
11. Kim JK, Wi JK & Youn JH (1996). Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes 45, 446-453.
12. Langberg H, Olesen JL, Gemmer C & Kjær M (2002). Substantial elevation of interleukin-6 concentration in peritendonous, but not muscle, following prolonged exercise. J Physiol 542, 985-990.
13. Lyngsø D, Simonsen L & Bülow J (2002). Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 543, 379-386.
14. Metzger S, Hassin T, Barash V, Pappo O & Chajek-Shaul T (2001). Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. Am J Physiol 281, E957-965.
15. Nybo L, Nielsen B, Pedersen BK, Møller K & Secher NH (2002). Interleukin-6 release from human brain during exercise. J Physiol 542, 991-995.
16. Pedersen BK, Steensberg A & Schjerling P (2001). Muscle-derived interleukin-6: possible biological effects. J Physiol 536, 329-337.
17. Rådegran G (1997). Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 83, 1383-1388.
18. Randle PJ, Garland PB, Hales CN & Newsholme EA (1963). The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
19. Ren J-M & Hultman E (1989). Regulation of glycogenolysis in human skeletal muscle. J Appl Physiol 67, 2243-2248.
20. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA & Febbraio MA (2001). Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 533, 585-591.
21. Steensberg A, Febbraio MA, Osada T, Van Hall G, Saltin B & Pedersen BK (2001). Low glycogen content increases interleukin-6 production in contracting human skeletal muscle. J Physiol 537, 633-639.
22. Steensberg A, Keller C, van Hall G, Osada T, Schjerling P, Pedersen BK, Saltin B & Febbraio MA (2002). Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation. J Physiol 541, 273-281.
23. Steensberg A, Van Hall G, Osada T, Sacchetti M, Saltin B & Pedersen BK (2000). Production of interleukin-6 in contracting human skeletal muscles can account for the exercise induced increase in plasma interleukin-6. J Physiol 529, 237-242.
24. Stouthard JM, Romijn JA, Van Der Poll T, Endert E, Mein S, Bakker PJ, Veenhof CH & Sauerwein HP (1995). Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268, E813-819.
25. Stouthard JM, Oude Elferink RP & Sauerwein HP (1996). Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun 18, 241-245.
26. Tabata I, Suzuki Y, Fukunaga T, Yokozeki T, Akimi H & Funato K (1999). Resistance training affects GLUT-4 content in skeletal muscle of humans after 19 days of head-down bed rest. J Appl Physiol 86, 909-914.
27. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS & Chrousos GP (1997). Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82, 4167-4170.
28. Wallenius V, Wallenius K, Ahren B, Rudlin M, Carlsten H, Dickson SL, Ohlsson C & Jansson J-O (2002). Interleukin-6-deficient mice develop mature-onset obesity. Nature Med 8, 75-79.